The tests are based on the company's ICE COLD PCR technology, which preferentially enriches mutant DNA sequences in an excess of wild-type DNA.
The Munich-based firm will use the funds to bring its Pharos400 laser-based PCR molecular diagnostic platform to market.
A new study has found that an antigen-based rapid diagnostic test for Ebola could be more reliable under certain circumstances than a recently approved RT-PCR assay for the virus.
Money from the private placement will be used for general corporate and working capital purposes, including activities supporting its ICE COLD-PCR technology.
Experts at Vanderbilt discussed future expansion of its PREDICT program, and provided a glimpse at how doctors have responded to genomic information in EMRs.
In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.
The American Society of Human Genetics has issued a position statement on genetic testing of children.
The White House seeks to update how biotechnology products are regulated.
Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.
This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.